ダウンロード数: 450
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
16_0738.pdf | 459.9 kB | Adobe PDF | 見る/開く |
タイトル: | 膀胱腫瘍の再発に対するβ-glucuronidase阻害剤(SLA)の効果 |
その他のタイトル: | Preventive effect of beta-glucuronidase inhibitor (SLA) on recurrence of the bladder tumor |
著者: | 宮川, 美栄子 原田, 卓 吉田, 修 加藤, 篤二 |
著者名の別形: | Miyakawa, Mieko Harada, Takashi Yoshida, Osamu Kato, Tokuji |
キーワード: | Acetates/therapeutic use Adipic Acids/therapeutic use Aged Female Glucuronidase/antagonists & inhibitors Humans Lactones/therapeutic use Male Middle Aged Neoplasm Recurrence, Local/prevention & control Urinary Bladder Neoplasms/prevention & control |
発行日: | Dec-1970 |
出版者: | 京都大学医学部泌尿器科学教室 |
誌名: | 泌尿器科紀要 |
巻: | 16 |
号: | 12 |
開始ページ: | 738 |
終了ページ: | 744 |
抄録: | Thirty-one patients with pedunculated, non-infiltrative tumor of the bladder was continuously administered SLA, beta-glucuronidase inhibitor, after surgery. The recurrence rate of the SLA-treatment group was 12.9 % within six months, 38.1 % within one year, 50.0 % within two year, and 81.8 % within three year. This result was compared with the recurrence rate of the non-prevention group in the preceding paper. Within the first two years, the recurrence rate was always lower in the SLA-group though not so significantly by statistical analysis. Some cases obviously showed the preventive effect of SLA against recurrence of tumor of the bladder. One patient complained of anorexia and nausea due to SLA, which was discontinued after two months administration. |
URI: | http://hdl.handle.net/2433/121208 |
PubMed ID: | 5531642 |
出現コレクション: | Vol.16 No.12 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。